Biotech Stocks To Watch And Pharma Industry News

Track the latest trends and leading stocks in the biotech and pharmaceutical industries.

The post Biotech Stocks To Watch And Pharma Industry News appeared first on Investor's Business Daily.

[Collection]

One minute Dow Jones industrial average component Merck (MRK) might be doing battle with fellow drugmaker Bristol-Myers Squibb (BMY) over drugs that can ward off cancer.

X

The next, biotech giants like Amgen (AMGN) and Sanofi (SNY) are tussling in court over the fate of cholesterol-busting drugs. Meanwhile, a company like Gilead Sciences (GILD) might be raked over the coals in Congress for charging $1,000 a day to treat hepatitis.

It's a brave — and contentious — new world for pharmaceutical and biotechnology companies. It's a realm where science is trying to develop landmark medicines that cure cancer, hepatitis and other life-threatening illnesses.

All the while it does a delicate dance with Wall Street and regulators — balancing public health issues with the demands of shareholders. Investors will find it tricky to navigate the sector, as companies can rise and fall at the drop of a hat.

Bookmark this page to stay on top of the latest news in the biopharma sector.

Biotech And Pharma News

Cannabis medicine biotech stocks pharma companies
Which Biopharma Stocks Are Looking To Score Big In Cannabis Medicine?Lost in the fray of countless efforts to bring recreational marijuana to a storefront near you, the advent of cannabis medicine by biotech stocks and pharma companies hit several key milestones in... Read More
Ultragenyx stock gene therapy
This Biotech Stock Is Flying On Its Promising Gene TherapyUltragenyx Pharmaceutical jumped Friday after its gene therapy showed promise in patients with an inherited disease that causes low blood sugar. On the stock market today, Ultragenyx stock leapt 7.9%, to 43,... Read More
CRISPR gene editing sickle cell disease
These Stocks Pop After FDA Expedites Review Of Gene-Editing TherapyCrispr Therapeutics popped Friday after the Food and Drug Administration announced plans to expedite review of its Vertex Pharmaceuticals-partnered gene-editing treatment. On the stock market today, Crispr stock jumped 8%, to 30.27,... Read More
Celgene takeover Bristol stock
Bristol To Become Top 5 Pharma — And Other Fallout From Celgene TakeoverBristol-Myers Squibb will become a top five Big Pharma stalwart after its Celgene takeover, an analyst said Friday — referencing a deal others believe will kick off a buying spree in biotech. The... Read More
REIT
REIT Stocks, Medical Stocks Lead New Buys By The Best Mutual Funds In Down MarketAs Wall Street entered a bear market in Q4, the amount of money being invested by the best mutual funds shrank considerably. But they focused their pared-back investments in REIT stocks, as... Read More
apple store
Stock Market Rally Extends On Fed Chairman Powell, Jobs; Apple, Tesla, Delta Disappoint; Bristol-Myers Buys Celgene: Weekly ReviewThe stock market rally continued for the Dow Jones, S&P 500 index and Nasdaq composite, with most of the gains Friday on a strong jobs report, positive China news and a vow... Read More
Stocks To Watch: Novo Nordisk Sees RS Rating Rise To 85One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Novo Nordisk cleared that benchmark Friday, with a jump from 75 to 85 Friday. When... Read More

View More Biotech And Pharma Stock News

Get instant access to more trading ideas, exclusive stock lists and IBD proprietary ratings for only $5.

RELATED:

Best Stocks To Buy And Watch

The post Biotech Stocks To Watch And Pharma Industry News appeared first on Investor's Business Daily.

http://feedproxy.google.com/~r/BusinessRss/~3/K5zsmUmuL5I/

No comments:

Post a Comment